Supplements

Ashwagandha: preparations, stress and sleep research, interactions, and liver alerts

7 sources · Latest source check 2026-10-14 UTC

On this page

Ashwagandha is the plant Withania somnifera, used in Ayurvedic traditions. Supplements may contain root, leaf or extracts of both. Its alternate name “Indian ginseng” does not make it the same plant as ginseng. Ingredient names alone do not establish equivalent composition.[2]

Common labels do not identify one standardized product

Common labels do not identify one standardized product
Term	Meaning
Root versus root-and-leaf	Different plant parts can have different chemical composition.[2]
Extract	A preparation with an extraction process and concentration; products can differ.[2]
Withanolides	A group of compounds used to characterize some preparations.[2]
Adaptogen	A broad traditional/promotional concept of resistance to stress, not a precise clinical outcome.[2]

Sleep outcomes differ, even within one review

A 2021 systematic review included five randomized trials comparing ashwagandha extracts with placebo. It found an average improvement in its combined sleep outcome, with variation between studies. Some measures improved, but the Pittsburgh Sleep Quality Index and time in bed did not show clear differences in their smaller analysis pools.[3]

The review did not establish a significant quality-of-life improvement. It also stressed limited serious-harm data and the need for longer safety study. A promising average sleep result is therefore different from proof that every product treats insomnia or that uninterrupted use for years is safe.[3]

Hormones and medicines make “natural” an incomplete safety description

NCCIH advises avoiding use in pregnancy and breastfeeding and identifies thyroid or autoimmune disease, upcoming surgery and hormone-sensitive prostate cancer as relevant concerns. Possible interactions include sedatives, thyroid medicines, immunosuppressants and medicines affecting blood pressure or glucose. A product can be relevant to a medical history even when purchased without a prescription.[1]

The same explanation describes drowsiness and gastrointestinal effects. Using a sleep-promoted ingredient alongside other sedating medicines is a different exposure from the extract used alone in a trial. The clinical context and full ingredient list matter.[1]

A small case series identifies a safety signal, not its frequency

A 2020 case series described five suspected ashwagandha-associated liver injuries from Iceland and the US Drug-Induced Liver Injury Network. Jaundice and itching were prominent, and injury was generally cholestatic or mixed. Other causes and available products were investigated, but some participants also used additional supplements.[4]

Such selected cases cannot calculate the chance of injury among all users or establish that every preparation causes it. They can still reveal a clinically important pattern that small efficacy trials are poorly equipped to detect. Benefit trials and safety surveillance answer complementary questions.[4]

A newer regulator alert adds information beyond older overviews

The TGA’s 7 July 2026 alert says liver-injury reports continue and that some earlier Australian cases required hospital care. New reports sometimes involved other potentially contributing ingredients. The regulator describes the risk as very rare, while acknowledging that injury can be serious.[5]

The alert advises stopping the product and seeking medical assessment for warning symptoms such as jaundice or dark urine. It also distinguishes sudden vomiting or diarrhea after one or two doses from possible liver injury, and advises avoiding these products with current or previous liver problems. These are Australian safety instructions, not a numerical incidence estimate.[5]

Severe case reports identify a concern without measuring its frequency

An Indian series reported eight liver-injury cases linked to single-ingredient ashwagandha products after excluding competing causes as far as possible. Several people had pre-existing liver disease, and severe outcomes occurred. This extends the safety concern beyond one report, but a selected case series has no denominator of all users. It cannot estimate the probability of harm for an average consumer.[6]

Evidence & uncertainty

Some preparations show promise for stress or sleep, but many studies are small and use different extracts. Anxiety evidence is less clear in the NCCIH overview. Long-term safety is not established, and a July 2026 Australian alert documents continuing reports of liver injury. Short-term tolerability is not a complete safety guarantee.[1][5]

Selected-source overview · Independent review pending

Published questions

Is ashwagandha actually the same plant as ginseng?

Selected-source overview · Independent review pending. Read the evidence context.

Ashwagandha and ginseng are different plants despite the alternate name “Indian ginseng.”[2]

Evidence behind this answer

Ashwagandha: Is it helpful for stress, anxiety, or sleep? Health Professional Fact Sheet
agency evidence explanation · Date not stated
Selected relevant official page passages inspected · Plant parts, adaptogen concept, extracts and qualified anxiety recommendation